60 DEGREES PHARMACEUTICALS, INC. Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
60 DEGREES PHARMACEUTICALS, INC. (SXTP) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $30.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-25.
Discontinued › Expense Statement › Interest Expense
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2023-08-25
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 6 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month |
|---|---|---|
| 2023-06-30 | $30.00K 10-Q · filed 2023-08-25 | |
| 2022-12-31 | $30.00K 10-Q · filed 2023-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 |